| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |